Matrix Dependent Rewiring of Signaling Pathways Following Targeted Therapies

1,388 views

|

March 17, 2016

  • Share
  • Joan Brugge, Ph.D., Chair of the Department of Cell Biology at Harvard Medical School, discussed her work examining pathways that allow for drug resistance of extracellular matrix-attached tumors.

    Cell Science

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.